Differential gene expression in human granulosa cells from recombinant FSH versus human menopausal gonadotropin ovarian stimulation protocols
<p>Abstract</p> <p>Background</p> <p>The study was designed to test the hypothesis that granulosa cell (GC) gene expression response differs between recombinant FSH and human menopausal gonadotropin (hMG) stimulation regimens.</p> <p>Methods</p> <p&...
Saved in:
Main Authors: | Bietz Mandi G (Author), Mueller Breanne A (Author), Eyster Kathleen (Author), Brannian John (Author), Hansen Keith (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
by: F. S. Mennini, et al.
Published: (2018) -
Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?
by: M. Kirshenbaum, et al.
Published: (2021) -
Recombinant FSH versus hMG in Controlled Ovarian Stimulation for IVF
by: Agus Supriyadi, et al.
Published: (2021) -
Effects of human menopausal gonadotropin on zona pellucida and pregnancy outcomes of ovarian stimulation protocols
by: Bing He, et al.
Published: (2015) -
Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization
by: Loredana Bergandi, et al.
Published: (2020)